Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.

@article{Muffly2017IncreasingUO,
  title={Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.},
  author={Lori Muffly and Marcelo C Pasquini and Michael Martens and Ruta Brazauskas and Xiaochun Zhu and Kehinde Adedeji Adekola and Mahmoud D. Aljurf and Karen Kuhn Ballen and Ashish Bajel and Fr{\'e}d{\'e}ric Baron and Minoo Battiwalla and Amer M Beitinjaneh and Jean-Yves Cahn and Mathew Carabasi and Yi-Bin Chen and Saurabh Chhabra and Stefan O Ciurea and Edward A. Copelan and Anita D'Souza and John Richard Edwards and James M Foran and Cesar Freytes and Henry Chi Hang Fung and Robert Peter Gale and Sergio A Giralt and Shahrukh K Hashmi and Gerhard C. Hildebrandt and Vincent T. Ho and Ann A. Jakubowski and Hillard M Lazarus and Marlise R. Luskin and Rodrigo Martino and Richard T Maziarz and Philip L McCarthy and Taiga Nishihori and Rebecca L. Olin and Richard F Olsson and Attaphol Pawarode and Edward Peres and Andrew R. Rezvani and David Alan Rizzieri and Bipin N Savani and Harry C. Schouten and Mitchell Sabloff and Matthew D. Seftel and Sachiko Seo and Mohamed L Sorror and Jeffrey Szer and Baldeep Mona Wirk and William A Wood and Andrew S. Artz},
  journal={Blood},
  year={2017},
  volume={130 9},
  pages={
          1156-1164
        }
}
In this study, we evaluated trends and outcomes of allogeneic hematopoietic cell transplantation (HCT) in adults ≥70 years with hematologic malignancies across the United States. Adults ≥70 years with a hematologic malignancy undergoing first allogeneic HCT in the United States between 2000 and 2013 and reported to the Center for International Blood and Marrow Transplant Research were eligible. Transplant utilization and transplant outcomes, including overall survival (OS), progression-free… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 27 CITATIONS

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia.

  • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2019

Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60–69 years with myelodysplastic syndrome

Hidehiro Itonaga, Ken Ishiyama, +15 authors Yasushi Miyazaki
  • Annals of Hematology
  • 2019
VIEW 2 EXCERPTS
CITES BACKGROUND

Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation

Juliane Grimm, Marius Bill, +12 authors Sebastian Schwind
  • Bone Marrow Transplantation
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 34 REFERENCES

Current Uses and Outcomes of Hematopoietic Cell Transplantation (HCT): CIBMTR Summary Slides, 2016

A D’Souza, X. Zhu
  • Available at: https://www.cibtmr.org. Accessed
  • 2017
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

  • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2013
VIEW 6 EXCERPTS

Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients.

  • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2013
VIEW 4 EXCERPTS

Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2012
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Reduced-intensity conditioning before allogeneic hematopoietic stem cell transplantation in patients over 60 years: a report from the SFGM-TC.

  • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2012
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL